CF PharmTech, Inc. released an announcement on 29 May 2026 detailing the latest composition of its Board of Directors and the three principal Board committees.

The Board now comprises ten members. Executive directors include Dr. Liang Bill Wenqing (also Chairperson), Dr. Li Li Bovet, Dr. Li Qi and Ms. Zhu Yuyu. Non-executive directors are Mr. Cai Lei and Dr. Yi Hua. Independent non-executive directors are Dr. Jin Jian, Ms. Wang Lijuan, Mr. Wei Shirong and Mr. Ip Wang Hoi.

Committee assignments have been adjusted as follows: • Audit Committee — chaired by Ms. Wang Lijuan with Dr. Liang Bill Wenqing and Dr. Jin Jian as members. • Remuneration and Appraisal Committee — chaired by Mr. Wei Shirong, joined by Ms. Zhu Yuyu and Dr. Jin Jian. • Nomination Committee — chaired by Mr. Ip Wang Hoi, with Dr. Jin Jian and Dr. Liang Bill Wenqing serving as members.

The updated governance structure reflects the company’s ongoing efforts to balance executive insight with independent oversight across its audit, remuneration and nomination functions.